相关实验视频
Updated: May 24, 2025
10:10
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
12.6K
微质介导的突触功能障碍有助于化疗相关的认知障碍
Jingxiong Wang1, Hua Zhang1, Marc Augenreich2
1Department of Medicine, University of Missouri-Columbia School of Medicine, Columbia, Missouri, USA.
Journal of neurochemistry
|February 28, 2025
概括
化疗通过影响微质细胞和突触可塑性而损害认知能力. 米诺环素治疗逆转了这些影响,这表明微质功能障碍驱动了化疗相关的认知障碍 (CRCI).
科学领域:
- 神经科学是一个神经科学.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 化疗相关的认知障碍 (CRCI) 是癌症幸存者面临的重大挑战.
- CRCI的潜在机制尚不清楚,这限制了有效的治疗开发.
- 微质和突触可塑性是CRCI病变发生的潜在关键因素.
研究的目的:
- 调查微质介导的突触可塑性缺陷是否有助于CRCI.
- 确定5-甲和leucovorin (5-Fu/LV) 对小鼠认知功能,微质活动和突触可塑性的影响.
- 评估米诺环林在缓解5-Fu/LV诱导的认知缺陷方面的治疗潜力.
主要方法:
- 成年雄性小鼠接受了5-Fu/LV化疗或载体治疗.
- 用新型对象识别 (NOR) 测试来评估认知功能.
- 微质形态和活性通过Iba1和CD68染色来评估.
- 测量了海马长期强化 (LTP) 和N-甲基-D-酸受体刺激后突触电流 (NMDAR-EPSCs).
- 小鼠同时接受微质抑制剂米诺环素的治疗.
主要成果:
- 在NOR测试中,5-Fu/LV治疗诱导认知缺陷.
- 化疗改变了微质形态,增加了CD68阳性微质,减少了细胞分裂.
- 5-Fu/LV降低了海马中的LTP和NMDAR-EPSCs.
- 米诺环素治疗恢复了认知功能,使微质变化正常化,并逆转了突触可塑性缺陷.
结论:
- 微质功能障碍,其特征是形态变化和减少的细胞化,与化疗诱导的认知障碍有关.
- 突触可塑性缺陷,特别是减少的LTP和NMDAR-EPSC,有助于CRCI.
- 用米诺环林等药物向微质活动可能为CRCI提供治疗策略.
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
92
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
92